Table 3.
Experimental group | % Vβ6+ CD3+ | % Vβ6+ CD4+ | % Vβ8+ CD3+ | % Vβ8+ CD4+ |
---|---|---|---|---|
Control BA | 8.99 ± 0.75 (n = 4) | 9.17 ± 0.09 (n = 3) | 17.18 ± 0.17 (n = 4) | 18.73 ± 0.27 (n = 3) |
Control AKR | 0.94 ± 1.1 (n = 2) | 0.08 ± 0.02 (n = 2) | 11.70 ± 0.85 (n = 2) | 11.51 (n = 1) |
BA HSC into AKR | 1.67 ± 0.12 (n = 2) | ND | 9.20 ± 3.68 (n = 2) | ND |
AKR HSC into BA | 0.36 ± 0.07 (n = 4) | 0.24 ± 0.1 (n = 4) | 16.53 ± 1.26 (n = 4) | 17.49 ± 0.68 (n = 4) |
ND, not determined.